Dacomitinib Intermediate 2 is a synthetic precursor of the EGFR inhibitor dacomitinib. This compound, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine, is used in cancer research, particularly for studying non-small cell lung cancer mechanisms in biochemical and cellular assays.
Molecular Weight:
348.72
Purity:
99.27% (May vary between batches)
CAS Number:
[179552-74-0]
Formula:
C15H10ClFN4O3
Target:
Others
Application Notes:
Solubility: DMSO:16.67 mg/mL (47.8 mM)
* VAT and and shipping costs not included. Errors and price changes excepted